Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - SYNOVIS LIFE TECHNOLOGIES INC | c58413exv99w1.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 26, 2010
SYNOVIS LIFE TECHNOLOGIES, INC.
(Exact name of Registrant as specified in its charter)
State of Incorporation: Minnesota
Commission File No.: 0-13907
I.R.S. Employer Identification No.: 41-1526554
Commission File No.: 0-13907
I.R.S. Employer Identification No.: 41-1526554
Address of principal executive offices:
2575 University Ave. W.
St. Paul, Minnesota 55114
2575 University Ave. W.
St. Paul, Minnesota 55114
Telephone Number: (651) 796-7300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition
On May 26, 2010, Synovis Life Technologies, Inc. (Synovis) issued a press release announcing its
earnings for the three and six months ended April 30, 2010. A copy of the press release is
furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Synovis will also
publish the press release, including the supplemental information contained therein, on its website
at www.synovislife.com.
The information contained in this report shall not be deemed to be filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of
that section, and shall not be incorporated by reference into any filings made by Synovis under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as
may be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits.
(99.1)
|
Synovis Life Technologies, Inc. News Release dated May 26, 2010. |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
SYNOVIS LIFE TECHNOLOGIES, INC. |
||||
Dated: May 26, 2010 | By: | /s/ Brett Reynolds | ||
Brett Reynolds | ||||
Vice-President of Finance, Chief Financial Officer and Corporate Secretary |
EXHIBIT INDEX
Exhibit | ||||
No. | Description | Method Of Filing | ||
(99.1)
|
Synovis Life Technologies, Inc. News Release dated May 26, 2010 | Filed herewith electronically. |